{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:21:48Z","timestamp":1781659308295,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.steroids.2011.07.002","type":"journal-article","created":{"date-parts":[[2011,7,21]],"date-time":"2011-07-21T06:35:16Z","timestamp":1311230116000},"page":"1351-1357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The steroid metabolome in lamotrigine-treated women with epilepsy"],"prefix":"10.1016","volume":"76","author":[{"given":"Martin","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Vrb\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Z\u00e1rubov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radmila","family":"Kancheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vel\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila","family":"Kancheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kub\u00e1tov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Du\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Marusi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton\u00edn","family":"Pa\u0159\u00edzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luboslav","family":"St\u00e1rka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2011.07.002_b0005","doi-asserted-by":"crossref","unstructured":"Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia, 2003; 44(Suppl. 4): 11\u201320.","DOI":"10.1046\/j.1528-1157.44.s4.2.x"},{"key":"10.1016\/j.steroids.2011.07.002_b0010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2165\/00003495-200363120-00002","article-title":"Polycystic ovary syndrome and epilepsy: a review of the evidence","volume":"63","author":"Meo","year":"2003","journal-title":"Drugs"},{"issue":"Suppl. 6","key":"10.1016\/j.steroids.2011.07.002_b0015","first-page":"S34","article-title":"Reproductive endocrine considerations and hormonal therapy for men with epilepsy","volume":"32","author":"Herzog","year":"1991","journal-title":"Epilepsia"},{"issue":"Suppl. 6","key":"10.1016\/j.steroids.2011.07.002_b0020","first-page":"S27","article-title":"Reproductive endocrine considerations and hormonal therapy for women with epilepsy","volume":"32","author":"Herzog","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/1381612003400263","article-title":"Current issues on epileptic women","volume":"6","author":"Pimentel","year":"2000","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.steroids.2011.07.002_b0030","first-page":"S42","article-title":"Epilepsy in women: the science of why it is special","volume":"53","author":"Morrell","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.steroids.2011.07.002_b0035","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1046\/j.1528-1157.2003.60702.x","article-title":"Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells","volume":"44","author":"Tauboll","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0040","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1528-1157.1998.tb01307.x","article-title":"Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication","volume":"39","author":"Stoffel-Wagner","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0045","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1212\/WNL.61.6_suppl_2.S27","article-title":"Reproductive dysfunction in women with epilepsy","volume":"61","author":"Isojarvi","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.steroids.2011.07.002_b0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00001756-200403010-00026","article-title":"Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol","volume":"15","author":"Reddy","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.steroids.2011.07.002_b0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1528-1167.2005.00705.x","article-title":"Anticonvulsant activity of androsterone and etiocholanolone","volume":"46","author":"Kaminski","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0060","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1210\/jcem.82.8.4161","article-title":"Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology","volume":"82","author":"Labrie","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.07.002_b0065","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1528-1167.2006.00826.x","article-title":"Differential effects of antiepileptic drugs on neuroactive steroids in men with epilepsy","volume":"47","author":"Herzog","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.eplepsyres.2007.04.009","article-title":"Sodium valproate versus lamotrigine: a randomised comparison of efficacy, tolerability and effects on circulating androgenic hormones in newly diagnosed epilepsy","volume":"75","author":"Stephen","year":"2007","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.steroids.2011.07.002_b0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.yebeh.2009.01.010","article-title":"Effects of valproate or lamotrigine monotherapy on the reproductive endocrine and insulin-related metabolic profile in Chinese adults with epilepsy: a prospective randomized study","volume":"14","author":"Kwan","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.steroids.2011.07.002_b0080","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yebeh.2009.07.033","article-title":"Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults","volume":"16","author":"Svalheim","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.steroids.2011.07.002_b0085","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jsbmb.2009.10.012","article-title":"Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor","volume":"121","author":"Hill","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.07.002_b0090","doi-asserted-by":"crossref","unstructured":"Hill M. et al. Elimination of cross-reactivity by addition of an excess of cross-reactant for radioimmunoassay of 17alpha-hydroxypregnenolone. Steroids, 1999; 64: 341\u201355.","DOI":"10.1016\/S0039-128X(99)00017-3"},{"key":"10.1016\/j.steroids.2011.07.002_b0095","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1515\/CCLM.2000.081","article-title":"Transformation in the PC-aided biochemical data analysis","volume":"38","author":"Meloun","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.steroids.2011.07.002_b0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1039\/b110779h","article-title":"Crucial problems in regression modelling and their solutions","volume":"127","author":"Meloun","year":"2002","journal-title":"Analyst"},{"key":"10.1016\/j.steroids.2011.07.002_b0105","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1528-1167.2005.10105.x","article-title":"Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations","volume":"46","author":"Reimers","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2125.2005.02539.x","article-title":"The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects","volume":"61","author":"Sidhu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.steroids.2011.07.002_b0120","doi-asserted-by":"crossref","unstructured":"Morrell MJ. et al. Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones. CNS Spectr, 2001; 6: 771\u20132, 783\u201386.","DOI":"10.1017\/S1092852900001528"},{"key":"10.1016\/j.steroids.2011.07.002_b0125","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.0013-9580.2005.38404.x","article-title":"Effects of anticonvulsants on human p450c17 (17alpha-hydroxylase\/17, 20 lyase) and 3beta-hydroxysteroid dehydrogenase type 2","volume":"46","author":"Fluck","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0306-4530(98)00009-2","article-title":"Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy","volume":"23","author":"Frye","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.steroids.2011.07.002_b0135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0773.1995.tb00164.x","article-title":"Effects of long-term antiepileptic therapy on the catabolism of testosterone","volume":"76","author":"Brunet","year":"1995","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.steroids.2011.07.002_b0140","first-page":"52","article-title":"Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy","volume":"21","author":"Murialdo","year":"1998","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.steroids.2011.07.002_b0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2008.01966.x","article-title":"Changes in sex steroid levels in women with epilepsy on treatment: relationship with antiepileptic therapies and seizure frequency","volume":"50","author":"Galimberti","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0150","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1528-1167.2006.00506.x","article-title":"Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy","volume":"47","author":"Lofgren","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0155","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1528-1167.2009.02178.x","article-title":"Seizure frequency and sex steroids in women with partial epilepsy on antiepileptic therapy","volume":"50","author":"Murialdo","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0920-1211(03)00042-1","article-title":"Inter-ictal and post-ictal circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in epileptic children","volume":"54","author":"Grosso","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.steroids.2011.07.002_b0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1196\/annals.1286.005","article-title":"Pathogenesis in menstrual cycle-linked CNS disorders","volume":"1007","author":"Backstrom","year":"2003","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.steroids.2011.07.002_b0170","first-page":"216","article-title":"Circulating levels of allopregnanolone, an anticonvulsant metabolite of progesterone, in women with partial epilepsy in the postcritical phase","volume":"42","author":"Galli","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.nurt.2009.01.009","article-title":"Hormonal therapies: progesterone","volume":"6","author":"Herzog","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.steroids.2011.07.002_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2009.02.017","article-title":"The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy","volume":"85","author":"Reddy","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.steroids.2011.07.002_b0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nurt.2009.01.006","article-title":"Neurosteroid replacement therapy for catamenial epilepsy","volume":"6","author":"Reddy","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.steroids.2011.07.002_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eplepsyres.2004.12.002","article-title":"Post-ictal circulating levels of allopregnanolone in children with partial or generalized seizures","volume":"63","author":"Grosso","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.steroids.2011.07.002_b0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-1211(03)00036-6","article-title":"Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy","volume":"54","author":"Stoffel-Wagner","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.steroids.2011.07.002_b0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00406-004-0499-9","article-title":"Impairment of inhibitory control of the hypothalamic pituitary adrenocortical system in epilepsy","volume":"254","author":"Zobel","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.steroids.2011.07.002_b0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.0013-9580.2005.59704.x","article-title":"Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment","volume":"46","author":"Galimberti","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0210","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1528-1167.2008.01555.x","article-title":"Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy","volume":"49","author":"Tuveri","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.steroids.2011.07.002_b0215","first-page":"317","article-title":"Serum ACTH levels in patients treated for epilepsy","volume":"28","author":"Motta","year":"1994","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.steroids.2011.07.002_b0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1203\/00006450-199909000-00018","article-title":"Corticotropin-releasing hormone as adrenal androgen secretagogue","volume":"46","author":"Ibanez","year":"1999","journal-title":"Pediatr Res"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11002261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11002261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:01:37Z","timestamp":1758535297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11002261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0039128X11002261"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.07.002","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The steroid metabolome in lamotrigine-treated women with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2011.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}